206 related articles for article (PubMed ID: 34519274)
1. Low serum 1,25(OH)2D3 in end-stage renal disease: is reduced 1α-hydroxylase the only problem?
Huish SA; Jenkinson C; Dunn JA; Meredith DJ; Bland R; Hewison M
Endocr Connect; 2021 Oct; 10(10):1291-1298. PubMed ID: 34519274
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.
Jolliffe DA; Stefanidis C; Wang Z; Kermani NZ; Dimitrov V; White JH; McDonough JE; Janssens W; Pfeffer P; Griffiths CJ; Bush A; Guo Y; Christenson S; Adcock IM; Chung KF; Thummel KE; Martineau AR
Am J Respir Crit Care Med; 2020 Aug; 202(3):371-382. PubMed ID: 32186892
[No Abstract] [Full Text] [Related]
5. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
6. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
[TBL] [Abstract][Full Text] [Related]
7. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D metabolism in living kidney donors before and after organ donation.
Enko D; Meinitzer A; Zelzer S; Herrmann M; Artinger K; Rosenkranz AR; Zitta S
Clin Chem Lab Med; 2022 Jul; 60(8):1218-1224. PubMed ID: 35514251
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial.
Lehmann U; Riedel A; Hirche F; Brandsch C; Girndt M; Ulrich C; Seibert E; Henning C; Glomb MA; Dierkes J; Stangl GI
Clin Nutr; 2016 Apr; 35(2):351-358. PubMed ID: 26037521
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of vitamin D3 by cytochromes P450.
Sakaki T; Kagawa N; Yamamoto K; Inouye K
Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
[TBL] [Abstract][Full Text] [Related]
12. The metabolism of a physiological dose of radioactive cholecalciferol (vitamin D3) to its hydroxylated metabolites in man.
Stanbury SW; Mawer EB
Clin Sci (Lond); 1980 Jun; 58(6):523-35. PubMed ID: 6253118
[TBL] [Abstract][Full Text] [Related]
13. Serum 24,25-dihydroxyvitamin D
Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
[TBL] [Abstract][Full Text] [Related]
14. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
Wang Y; Zhu J; DeLuca HF
Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial.
Martineau AR; Thummel KE; Wang Z; Jolliffe DA; Boucher BJ; Griffin SJ; Forouhi NG; Hitman GA
J Clin Endocrinol Metab; 2019 Dec; 104(12):5831-5839. PubMed ID: 31199458
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD.
Kaufmann M; Gallagher JC; Peacock M; Schlingmann KP; Konrad M; DeLuca HF; Sigueiro R; Lopez B; Mourino A; Maestro M; St-Arnaud R; Finkelstein JS; Cooper DP; Jones G
J Clin Endocrinol Metab; 2014 Jul; 99(7):2567-74. PubMed ID: 24670084
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.
Barger-Lux MJ; Heaney RP; Dowell S; Chen TC; Holick MF
Osteoporos Int; 1998; 8(3):222-30. PubMed ID: 9797906
[TBL] [Abstract][Full Text] [Related]
19. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
20. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
Tenenhouse HS; Jones G
Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
